Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
|
|
Urovant Sciences Ltd. (UROV)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/31/2021 |
4
| Robinson James A. Jr. (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 8,385 shares
@ $0
Disposed/sold 50,000 options to buy
@ $12.41, valued at
$620.5k
Disposed/sold 25,000 options to buy
@ $8.78, valued at
$219.5k
Disposed/sold 845,732 rights
@ $9.16, valued at
$7.7M
|
|
| 03/31/2021 |
4
| Haag-Molkenteller Cornelia (CMO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 11,603 shares
@ $0
Disposed/sold 129,745 shares
@ $0
Disposed/sold 146,850 options to buy
@ $7.53, valued at
$1.1M
Disposed/sold 1,000 options to buy
@ $13.65, valued at
$13.7k
Disposed/sold 100,000 options to buy
@ $6.88, valued at
$688k
|
|
| 03/31/2021 |
4
| Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 12,480 shares
@ $0
Disposed/sold 9,000 shares
@ $0
Disposed/sold 13,350 options to buy
@ $7.53, valued at
$100.5k
Disposed/sold 36,650 options to buy
@ $8.01, valued at
$293.6k
Disposed/sold 25,000 options to buy
@ $8.78, valued at
$219.5k
Disposed/sold 15,000 options to buy
@ $9.38, valued at
$140.7k
|
|
| 03/31/2021 |
4
| BANSAL AJAY (See Remarks) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 24,876 shares
@ $0
Disposed/sold 115,222 shares
@ $0
Disposed/sold 140,000 options to buy
@ $9.66, valued at
$1.4M
|
|
| 03/31/2021 |
4
| Hindman James M. (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 9,000 shares
@ $0
Disposed/sold 61,000 options to buy
@ $10.53, valued at
$642.3k
Disposed/sold 15,000 options to buy
@ $9.38, valued at
$140.7k
|
|
| 03/31/2021 |
4
| Kurstjens Sef (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 12,480 shares
@ $0
Disposed/sold 9,000 shares
@ $0
Disposed/sold 13,350 options to buy
@ $7.53, valued at
$100.5k
Disposed/sold 36,650 options to buy
@ $8.01, valued at
$293.6k
Disposed/sold 25,000 options to buy
@ $8.78, valued at
$219.5k
Disposed/sold 15,000 options to buy
@ $9.38, valued at
$140.7k
|
|
| 03/31/2021 |
4
| Johnston Walt (See Remarks) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 492 shares
@ $0
Disposed/sold 108,647 shares
@ $0
Disposed/sold 69,197 options to buy
@ $10.64, valued at
$736.3k
|
|
| 03/31/2021 |
4
| Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 9,341 shares
@ $0
Disposed/sold 115,106 shares
@ $0
Disposed/sold 93,450 options to buy
@ $7.53, valued at
$703.7k
Disposed/sold 3,500 options to buy
@ $13.65, valued at
$47.8k
Disposed/sold 20,000 options to buy
@ $6.88, valued at
$137.6k
|
|
| 03/31/2021 |
4
| OCAMPO CHRISTINE (PAO; CAO/Urovant Sciences,Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 9,810 shares
@ $0
Disposed/sold 68,971 shares
@ $0
Disposed/sold 133,500 options to buy
@ $3.64, valued at
$485.9k
Disposed/sold 3,750 options to buy
@ $13.65, valued at
$51.2k
Disposed/sold 70,000 options to buy
@ $6.88, valued at
$481.6k
|
|
| 03/31/2021 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Disposed/sold 12,480 shares
@ $0
Disposed/sold 9,000 shares
@ $0
Disposed/sold 50,000 options to buy
@ $8.01, valued at
$400.5k
Disposed/sold 25,000 options to buy
@ $8.78, valued at
$219.5k
Disposed/sold 15,000 options to buy
@ $9.38, valued at
$140.7k
|
|
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/08/2021 |
4
| Haag-Molkenteller Cornelia (CMO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Paid exercise price by delivering 5,810 shares
@ $16.09, valued at
$93.5k
|
|
| 01/08/2021 |
4
| Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Paid exercise price by delivering 4,761 shares
@ $16.09, valued at
$76.6k
|
|
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2020 |
4
| Johnston Walt (SVP, Commercial, USI) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 108,647 shares
@ $0
Granted 69,197 options to buy
@ $10.64, valued at
$736.3k
|
|
| 06/03/2020 |
3
| Johnston Walt (SVP, Commercial, USI) has filed a Form 3 on Urovant Sciences Ltd. |
| 06/01/2020 |
4
| Hindman James M. (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 61,000 options to buy
@ $10.53, valued at
$642.3k
|
|
| 06/01/2020 |
3
| Hindman James M. (Director) has filed a Form 3 on Urovant Sciences Ltd. |
| 05/04/2020 |
4
| Haag-Molkenteller Cornelia (CMO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 83,149 shares
@ $0 |
|
| 05/04/2020 |
4
| Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 77,606 shares
@ $0 |
|
| 05/04/2020 |
4
| OCAMPO CHRISTINE (PAO;CAO/Urovant Sciences, Inc) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 44,346 shares
@ $0 |
|
| 05/04/2020 |
4
| BANSAL AJAY (PFO;CFO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 63,659 shares
@ $0 |
|
| 03/25/2020 |
4
| Robinson James A. Jr. (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 845,732 rights
@ $9.16, valued at
$7.7M
|
|
| 02/21/2020 |
4
| Katkin Keith (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Paid exercise price by delivering 104,788 shares
@ $13.08, valued at
$1.4M
Disposed of 75,212 shares
@ $13.08, valued at
$983.8k
Exercised 180,000 options to buy
@ $3.86, valued at
$694.8k
|
|
| 02/21/2020 |
4
| Smith Bryan E. (GC/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Paid exercise price by delivering 34,835 shares
@ $13.08, valued at
$455.6k
Disposed of 15,165 shares
@ $13.08, valued at
$198.4k
Exercised 50,000 options to buy
@ $6.88, valued at
$344k
|
|
| 02/21/2020 |
4
| Sumitomo Chemical Co., Ltd. (See Footnote (1)) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Bought 12,873 shares
@ $13.08, valued at
$168.4k
Bought 15,165 shares
@ $13.08, valued at
$198.4k
Bought 75,212 shares
@ $13.08, valued at
$983.8k
|
|
| 01/14/2020 |
4
| Robinson James A. Jr. (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 12,480 shares
@ $0 |
|
| 01/14/2020 |
4
| POTTER MYRTLE S (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 12,480 shares
@ $0 |
|
| 01/14/2020 |
4
| Legault Pierre (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 12,480 shares
@ $0 |
|
| 01/14/2020 |
4
| Kurstjens Sef (Director) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 12,480 shares
@ $0 |
|
| 01/09/2020 |
4
| Katkin Keith (PEO;CEO/Urovant Sciences, Inc.) has filed a Form 4 on Urovant Sciences Ltd.|
Txns:
| Granted 199,680 shares
@ $0 |
|
|
|
|